On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...